StockClub
DNTHDianthus Therapeutics, Inc.$ --
Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc.

DNTH

$ -

-

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

analyticsIncome Statement Summary

FY2025 Full YearUpdated: 12/31/2025

Revenue

attach_money
2M USD
YoY -67.3%

Operating Income

bar_chart
-178M USD
YoY -74.7%

Net Income

verified
-162M USD
YoY -91.1%

EPS

pie_chart
-4.2USD
YoY -64.7%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income
No quarterly data available

Full-Year Progress

FY2025
Net Income Progress0%Below Target
Revenue Progress2M
Revenue Forecast2.2M
Net Income Progress0
Net Income Forecast-162.3M

Income Statement Details

Item
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Revenue
Cost of revenue
Gross profit
2
0
2
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
146
0
34
180
-178
Interest expense
Income before tax
Income tax expense
Net income
0
-162
0
-162

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.